Adaptimmune Therapeutics
ADAP
#10858
Rank
A$20.84 M
Marketcap
A$0.07866
Share price
0.00%
Change (1 day)
2.97%
Change (1 year)

Annual Reports (20-F)

Latest form 20-F annual reports for Adaptimmune Therapeutics CIK: 0001621227

Thumbnail Adaptimmune Therapeutics 20-F Annual Report 2015

20-F Annual Report 2015

Language: English

View Annual Report (20-F)
Thumbnail Adaptimmune Therapeutics 20-F Annual Report 2015

20-F Annual Report 2015

Language: English

View Annual Report (20-F)